http://rdf.ncbi.nlm.nih.gov/pubchem/reference/20128157

Outgoing Links

Predicate Object
contentType Journal Article|Meta-Analysis
endingPage 82
issn 1470-2045
issueIdentifier 1
pageRange 65-82
publicationName The Lancet. Oncology
startingPage 65
bibliographicCitation Bangalore S, Kumar S, Kjeldsen SE, Makani H, Grossman E, Wetterslev J, Gupta AK, Sever PS, Gluud C, Messerli FH. Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324,168 participants from randomised trials. Lancet Oncol. 2011 Jan;12(1):65–82. doi: 10.1016/s1470-2045(10)70260-6. PMID: 21123111.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_45285517f5e3e8044b02ed388d566916
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_42d9078de392cd1a3206e0e84a23f8b3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_64d6a60c05d15e586275a3426f35506f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-8861-0799
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-5807-8503
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-9485-0652
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-7778-1771
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bb449bdd0ae031884296223005510041
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_20ebb78cacdb67f1606514cb6bc0e7ac
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_83fec4eb18d03d966d78e394137506d5
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bdbc1a41f83ce25379ee8824eed8a4b5
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5b413835ccab2b36e4e52ea7191e404f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-8353-0661
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d49bdc6ef380a54208dd51663d5716df
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_78b8012968d18cf116a52aa9fdfb577f
date 201101
identifier https://doi.org/10.1016/s1470-2045%2810%2970260-6
https://pubmed.ncbi.nlm.nih.gov/21123111
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/27004
https://portal.issn.org/resource/ISSN/1470-2045
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324 168 participants from randomised trials
discusses http://id.nlm.nih.gov/mesh/M0539833
http://id.nlm.nih.gov/mesh/M0001207
http://id.nlm.nih.gov/mesh/M0001456
http://id.nlm.nih.gov/mesh/M0003165
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D009369Q000139
http://id.nlm.nih.gov/mesh/D000959Q000009
hasSubjectTerm http://id.nlm.nih.gov/mesh/D057911Q000009
http://id.nlm.nih.gov/mesh/D012306
http://id.nlm.nih.gov/mesh/D006973Q000188
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D000806Q000008
http://id.nlm.nih.gov/mesh/D000806Q000009
http://id.nlm.nih.gov/mesh/D002121Q000009
http://id.nlm.nih.gov/mesh/D016032
http://id.nlm.nih.gov/mesh/D002121Q000008
http://id.nlm.nih.gov/mesh/D057911Q000008
http://id.nlm.nih.gov/mesh/D004359
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_9ffa6b56d06ddd0c9bc50088955e425b
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_360e2ece07507675dced80ba867d6dcd

Total number of triples: 52.